PyInvesting

Market research

AARTIDRUGS.NSE Aarti Drugs Limited

NSE INR Healthcare

Latest close

489.95 —

As of Nov 11, 2026

Test a moving-average rule with historical data.

Market facts

Market cap
46B
P/E ratio
23.88
Analyst target
474
Dividend yield
0.0%
Beta
0.26

Community

Investor discussion

1 comment

Admin profile picture
Admin

Apr 1, 2021

Aarti Drugs Limited is currently in a long term uptrend where the price is trading 1.8% above its 200 day moving average.

From a valuation standpoint, the stock is 35.3% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 3.1.

Aarti Drugs Limited's total revenue rose by 12.0% to $5B since the same quarter in the previous year.

Its net income has increased by 144.9% to $680M since the same quarter in the previous year.

Finally, its free cash flow fell by 42.8% to $583M since the same quarter in the previous year.

Based on the above factors, Aarti Drugs Limited gets an overall score of 4/5.